APO RESEARCH · REPORT
Anti-Peptic Ulcer Drugs
Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.
Product & engineering
Understand the product.
Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.
Selected research
Industry Research
Anti-Peptic Ulcer Drugs Industry Research Report 2026
Market perspective
Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.
Global Anti-Peptic Ulcer Drugs key players include AstraZeneca, Ask-pharm, Takeda, Yangtze River Pharm, Shandong Luoxin, etc. Global top five players hold a share about 50%.
In terms of product, the segment includes Proton Pump Inhibitors (PPIs), Potassium-Competitive Acid Blockers (P-CAB), Antacids, H2 Antagonists, Ulcer Protective Drugs. And in terms of application, the application includes Gastritis, Gastric Ulcers, Duodenal Ulcers, Gastroesophageal Reflux Disease (GERD).
Read the full market overview
Report Scope
This report quantifies the global Anti-Peptic Ulcer Drugs market in terms of revenue (US$ million) and, where applicable, service volume (K MT), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K MT) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Anti-Peptic Ulcer Drugs.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Anti-Peptic Ulcer Drugs Market by Company
AstraZeneca
Ask-pharm
Takeda
Yangtze River Pharm
Shandong Luoxin
Huadong Medicine
Changzhou Siyao
Beijing Yuekang
Guangdong Dahua
Xian Janssen
Anti-Peptic Ulcer Drugs Segment by Type
Proton Pump Inhibitors (PPIs)
Potassium-Competitive Acid Blockers (P-CAB)
Antacids
H2 Antagonists
Ulcer Protective Drugs
Anti-Peptic Ulcer Drugs Segment by Application
Gastritis
Gastric Ulcers
Duodenal Ulcers
Gastroesophageal Reflux Disease (GERD)
Anti-Peptic Ulcer Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Peptic Ulcer Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-Peptic Ulcer Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Peptic Ulcer Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Anti-Peptic Ulcer Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Proton Pump Inhibitors (PPIs)
- Potassium-Competitive Acid Blockers (P-CAB)
- Antacids
- H2 Antagonists
- Ulcer Protective Drugs
Applications
- Gastritis
- Gastric Ulcers
- Duodenal Ulcers
- Gastroesophageal Reflux Disease (GERD)
Companies covered
- AstraZeneca
- Ask-pharm
- Takeda
- Yangtze River Pharm
- Shandong Luoxin
- Huadong Medicine
- Changzhou Siyao
- Beijing Yuekang
- Guangdong Dahua
- Xian Janssen
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Anti-Peptic Ulcer Drugs by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Proton Pump Inhibitors (PPIs)
- 2.2.3 Potassium-Competitive Acid Blockers (P-CAB)
- 2.2.4 Antacids
- 2.2.5 H2 Antagonists
- 2.2.6 Ulcer Protective Drugs
- 2.3 Anti-Peptic Ulcer Drugs by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Gastritis
- 2.3.3 Gastric Ulcers
- 2.3.4 Duodenal Ulcers
- 2.3.5 Gastroesophageal Reflux Disease (GERD)
- 2.4 Assumptions and Limitations
3 Anti-Peptic Ulcer Drugs Breakdown Data by Type
- 3.1 Global Anti-Peptic Ulcer Drugs Historic Market Size by Type (2021-2026)
- 3.2 Global Anti-Peptic Ulcer Drugs Forecasted Market Size by Type (2027-2032)
4 Anti-Peptic Ulcer Drugs Breakdown Data by Application
- 4.1 Global Anti-Peptic Ulcer Drugs Historic Market Size by Application (2021-2026)
- 4.2 Global Anti-Peptic Ulcer Drugs Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Anti-Peptic Ulcer Drugs Market Perspective (2021-2032)
- 5.2 Global Anti-Peptic Ulcer Drugs Growth Trends by Region
- 5.2.1 Global Anti-Peptic Ulcer Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Anti-Peptic Ulcer Drugs Historic Market Size by Region (2021-2026)
- 5.2.3 Anti-Peptic Ulcer Drugs Forecasted Market Size by Region (2027-2032)
- 5.3 Anti-Peptic Ulcer Drugs Market Dynamics
- 5.3.1 Anti-Peptic Ulcer Drugs Industry Trends
- 5.3.2 Anti-Peptic Ulcer Drugs Market Drivers
- 5.3.3 Anti-Peptic Ulcer Drugs Market Challenges
- 5.3.4 Anti-Peptic Ulcer Drugs Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Anti-Peptic Ulcer Drugs Players by Revenue
- 6.1.1 Global Top Anti-Peptic Ulcer Drugs Players by Revenue (2021-2026)
- 6.1.2 Global Anti-Peptic Ulcer Drugs Revenue Market Share by Players (2021-2026)
- 6.2 Global Anti-Peptic Ulcer Drugs Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Anti-Peptic Ulcer Drugs Head Office and Area Served
- 6.4 Global Anti-Peptic Ulcer Drugs Players, Product Type & Application
- 6.5 Global Anti-Peptic Ulcer Drugs Manufacturers Established Date
- 6.6 Global Anti-Peptic Ulcer Drugs Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Anti-Peptic Ulcer Drugs Market Size (2021-2032)
- 7.2 North America Anti-Peptic Ulcer Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Anti-Peptic Ulcer Drugs Market Size by Country (2021-2026)
- 7.4 North America Anti-Peptic Ulcer Drugs Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Anti-Peptic Ulcer Drugs Market Size (2021-2032)
- 8.2 Europe Anti-Peptic Ulcer Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Anti-Peptic Ulcer Drugs Market Size by Country (2021-2026)
- 8.4 Europe Anti-Peptic Ulcer Drugs Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Anti-Peptic Ulcer Drugs Market Size (2021-2032)
- 9.2 Asia-Pacific Anti-Peptic Ulcer Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Anti-Peptic Ulcer Drugs Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Anti-Peptic Ulcer Drugs Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Anti-Peptic Ulcer Drugs Market Size (2021-2032)
- 10.2 South America Anti-Peptic Ulcer Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Anti-Peptic Ulcer Drugs Market Size by Country (2021-2026)
- 10.4 South America Anti-Peptic Ulcer Drugs Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Anti-Peptic Ulcer Drugs Market Size (2021-2032)
- 11.2 Middle East & Africa Anti-Peptic Ulcer Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Anti-Peptic Ulcer Drugs Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Anti-Peptic Ulcer Drugs Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 AstraZeneca
- 12.1.1 AstraZeneca Company Information
- 12.1.2 AstraZeneca Business Overview
- 12.1.3 AstraZeneca Revenue in Anti-Peptic Ulcer Drugs Business (2021-2026)
- 12.1.4 AstraZeneca Anti-Peptic Ulcer Drugs Product Portfolio
- 12.1.5 AstraZeneca Recent Developments
- 12.2 Ask-pharm
- 12.2.1 Ask-pharm Company Information
- 12.2.2 Ask-pharm Business Overview
- 12.2.3 Ask-pharm Revenue in Anti-Peptic Ulcer Drugs Business (2021-2026)
- 12.2.4 Ask-pharm Anti-Peptic Ulcer Drugs Product Portfolio
- 12.2.5 Ask-pharm Recent Developments
- 12.3 Takeda
- 12.3.1 Takeda Company Information
- 12.3.2 Takeda Business Overview
- 12.3.3 Takeda Revenue in Anti-Peptic Ulcer Drugs Business (2021-2026)
- 12.3.4 Takeda Anti-Peptic Ulcer Drugs Product Portfolio
- 12.3.5 Takeda Recent Developments
- 12.4 Yangtze River Pharm
- 12.4.1 Yangtze River Pharm Company Information
- 12.4.2 Yangtze River Pharm Business Overview
- 12.4.3 Yangtze River Pharm Revenue in Anti-Peptic Ulcer Drugs Business (2021-2026)
- 12.4.4 Yangtze River Pharm Anti-Peptic Ulcer Drugs Product Portfolio
- 12.4.5 Yangtze River Pharm Recent Developments
- 12.5 Shandong Luoxin
- 12.5.1 Shandong Luoxin Company Information
- 12.5.2 Shandong Luoxin Business Overview
- 12.5.3 Shandong Luoxin Revenue in Anti-Peptic Ulcer Drugs Business (2021-2026)
- 12.5.4 Shandong Luoxin Anti-Peptic Ulcer Drugs Product Portfolio
- 12.5.5 Shandong Luoxin Recent Developments
- 12.6 Huadong Medicine
- 12.6.1 Huadong Medicine Company Information
- 12.6.2 Huadong Medicine Business Overview
- 12.6.3 Huadong Medicine Revenue in Anti-Peptic Ulcer Drugs Business (2021-2026)
- 12.6.4 Huadong Medicine Anti-Peptic Ulcer Drugs Product Portfolio
- 12.6.5 Huadong Medicine Recent Developments
- 12.7 Changzhou Siyao
- 12.7.1 Changzhou Siyao Company Information
- 12.7.2 Changzhou Siyao Business Overview
- 12.7.3 Changzhou Siyao Revenue in Anti-Peptic Ulcer Drugs Business (2021-2026)
- 12.7.4 Changzhou Siyao Anti-Peptic Ulcer Drugs Product Portfolio
- 12.7.5 Changzhou Siyao Recent Developments
- 12.8 Beijing Yuekang
- 12.8.1 Beijing Yuekang Company Information
- 12.8.2 Beijing Yuekang Business Overview
- 12.8.3 Beijing Yuekang Revenue in Anti-Peptic Ulcer Drugs Business (2021-2026)
- 12.8.4 Beijing Yuekang Anti-Peptic Ulcer Drugs Product Portfolio
- 12.8.5 Beijing Yuekang Recent Developments
- 12.9 Guangdong Dahua
- 12.9.1 Guangdong Dahua Company Information
- 12.9.2 Guangdong Dahua Business Overview
- 12.9.3 Guangdong Dahua Revenue in Anti-Peptic Ulcer Drugs Business (2021-2026)
- 12.9.4 Guangdong Dahua Anti-Peptic Ulcer Drugs Product Portfolio
- 12.9.5 Guangdong Dahua Recent Developments
- 12.10 Xian Janssen
- 12.10.1 Xian Janssen Company Information
- 12.10.2 Xian Janssen Business Overview
- 12.10.3 Xian Janssen Revenue in Anti-Peptic Ulcer Drugs Business (2021-2026)
- 12.10.4 Xian Janssen Anti-Peptic Ulcer Drugs Product Portfolio
- 12.10.5 Xian Janssen Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst